Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Nicoletta Lanese Live Science Science journalist. New York, USA sciencehealthjournalism	When will MDMA be approved for therapy? Major trial issues may stand in the way, psychiatrist Dr. Albino Oliveira-Maia says. - 9 days ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	MindMed begins phase 3 study of MM120 for anxiety disorder - 9 days ago
3	The Editors of ARTnews Artnews Trusted art news source. Artnews	Diriyah Art Futures Announces First-Ever Mazra’ah Media Arts Residency for Established Artists and Scholars - 22 days ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Modified Donanemab Dosing May Reduce ARIA-E Risk in Early Alzheimer's - 23 days ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 6 months ago Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer - 12 months ago Improvements With Guselkumab in Psoriatic Arthritis Seen Across All MDA Domains - about 1 year ago MS Treatment-Discontinuation Study Terminated After Disease Activity Returns - about 1 year ago
5	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	Medtech Europe calls for urgent reform of MDR and IVDR - 2 months ago EMA updates advice on drug-device combinations under MDR, IVDR - 7 months ago FDA authorizes record number of new devices in 2023 - 11 months ago FDA shares draft medical device harmonization plan to meet MDUFA V goal - over 1 year ago FDA makes device conformity testing scheme permanent to streamline assessments - over 1 year ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts Resubmitted NDA for AXS-07 for Acute Treatment of Migraine - 4 months ago FDA Declines to Approve MDMA for PTSD - 5 months ago Is 2024 the Year for Psychedelic Medicine? - 9 months ago FDA Accepts New Drug Application for MDMA-Assisted Therapy for PTSD - 11 months ago
7	Kristen Monaco MedPage Today	More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 4 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 5 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 10 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - about 1 year ago ADHD and Dementia; Alleged Sex Assault in MDMA Trial; iPhones Screen for Depression - about 1 year ago
8	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 4 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 4 months ago A tough week for MDMA-assisted psychotherapy - 5 months ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - 5 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 5 months ago Psychedelic investment continues to ramp up - 11 months ago
9	Monica Castillo Mashable Senior film programmer. Critic. Dog pictures enthusiast. Graduated from USC Annenberg, BU Tweets. Cuban-American. New York, USA film programmingcriticism	'Daughters' review: Emotional documentary offers an honest look at how incarceration affects families - 4 months ago
10	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Uncertain Path Forward for Psychedelic Medicine - 4 months ago The FDA Just Rejected a Bid for MDMA to Treat PTSD - 5 months ago The Case for MDMA’s Approval Is Riddled With Problems - 7 months ago

Journalists covering MDA